Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | MODERN MEDICAL HALL | 2 | ₹8,400 |
| 2 | Schedule 4 | ALBINO LIFESCIENCES PRIVATE LIMITED | 1 | ₹1.3 L |
| 3 | Schedule 5 | MODERN MEDICAL HALL | 1 | ₹5.0 L |
| 4 | Schedule 8 | GAGAN ASSOCIATES | 1 | ₹31,080 |
Tender Value
₹7.2 L
EMD Value
Exempted
Closing Date
23 Aug 2025, 12:00 pmClosed
Leuprolide 11 point 25 mg per Vial
Zoledronic Acid 5 mg Inj
Inj ACTH long acting 60IU per ml vial of 5 ml
INJ SOMATROGON 60MG per 1 pont 2ML
Romosozumab 105 mg 1 point 17 ml Inj
Inj Glucagon 1 mg
Triptorelin acetate 0 point 1mg Inj
INSULIN GLARGINE 100IU per ML plus LIXISENATIDE 50MCG per ML INJ
8141774
GEM/2025/B/6499195
Two Packet Bid
Romosozumab 105 mg 1 point 17 ml Inj
28 days
PANCHKULA
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹4 L
₹4 L
50%
Exempted
23 Aug 2025
11 Aug 2025
23 Aug 2025
Endocrinology Drugs
Leuprolide 11 point 25 mg per Vial
Zoledronic Acid 5 mg Inj
Inj ACTH long acting 60IU per ml vial of 5 ml
INJ SOMATROGON 60MG per 1 pont 2ML
Romosozumab 105 mg 1 point 17 ml Inj
Inj Glucagon 1 mg
Triptorelin acetate 0 point 1mg Inj
INSULIN GLARGINE 100IU per ML plus LIXISENATIDE 50MCG per ML INJ
ENDOCRINE DRUGS
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8141774.pdf
GEM_BID
atc2_d8b5b8c8-0244-4718-86f81753506330008_mandeep.sharma.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
bbqr_medicine_2025-07-26-10-00-57_037004a833e600718fd67a007989debf.pdf
BOQ
70_endo_2025-07-26-10-00-57_13de735c38b1ab66dce2c0646157bca2.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .